In a major step toward addressing the growing threat of dangerous synthetic drugs in Illinois, the Senate has passed legislation chief co-sponsored by State Senator Sally Turner (R-Beason) to more strictly regulate xylazine, a powerful animal tranquilizer that is increasingly being found in the illicit drug supply.
Senate Bill 1773 amends the Illinois Controlled Substances Act to classify xylazine as a Schedule III controlled substance. The measure responds to a disturbing rise in overdose cases involving the drug, often referred to as the “zombie drug.” In addition to strengthening criminal penalties for the unlawful possession or distribution of xylazine, Senate Bill 1773 includes important protections for legitimate veterinary and wildlife use.
“We are seeing a rise in dangerous substances like xylazine being mixed with fentanyl and other illicit drugs, often without the user even knowing,” said Senator Sally Turner. “This legislation ensures Illinois law keeps pace with this growing threat and gives law enforcement and public health officials the tools they need to respond.”
Data from the Illinois Department of Public Health shows that xylazine was detected in 45 overdose deaths in 2020 and in more than 200 deaths by 2022. While not approved for human use, xylazine is often used to enhance the effects of other drugs, making it especially dangerous and difficult to treat.
“This is exactly the kind of emerging threat that lawmakers need to take seriously,” continued Senator Turner. “We cannot wait until more lives are lost before we act. This bill is about being proactive, protecting our communities, and giving law enforcement the tools they need to respond.”
Senator Sally Turner’s support for Senate Bill 1773 is part of her broader efforts to strengthen the state’s response to synthetic drugs and the opioid epidemic. The legislation now moves to the House for consideration.